C32H33N5O4
Neat
551.65
142217-77-4; (1S, 2S, 3S, 5S)-5-(2-Amino-6-(benzyloxy)-9H-purin-9-yl)-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol; Cyclopentanol, 5-[2-amino-6-(phenylmethoxy)-9H-purin-9-yl]-3-(phenylmethoxy)-2-[(phenylmethoxy)methyl]-, (1S, 2S, 3S, 5S)-; C32H33N5O4; MFCD09750977; (1S, 2S, 3S, 5S)-5-(2-amino-6-phenylmethoxypurin-9-yl)-3-phenylmethoxy-2-(phenylmethoxymethyl)cyclopentan-1-ol; Entecavir Intermediate IV; (1S, 2S, 3S, 5S)-5-[2-Amino-6-(benzyloxy)-9H-purin-9-yl]-3-(benzyloxy)-2-(benzyloxymethyl)cyclopentanol; Entecavir Impurity 60; SCHEMBL2519691; SCHEMBL30303062; DTXSID90672073; AKOS015896664; AC-5919; NA32025; (1S, 2S, 3S, 5S)-5-(2-amino-6-benzyloxy-purin-9-yl)-3-benzyloxy-2-(benzyloxymethyl)cyclopentanol; (1S, 2S, 3S and 5S)-5-[2-Amino-6-(benzyloxy)-9H-purin-9-yl]-3-(benzyloxy)-2-[(benzyloxy)methyl]cyclopentan-1-ol; DS-12112; SY013728; CS-0156210
(1S, 2S, 3S and 5S)-5-(2-amino-6-phenylmethoxypurin-9-yl)-3-phenylmethoxy-2-(phenylmethoxymethyl)cyclopentan-1-ol
InChI=1S/C32H33N5O4/c33-32-35-30-28(31(36-32)41-19-24-14-8-3-9-15-24)34-21-37(30)26-16-27(40-18-23-12-6-2-7-13-23)25(29(26)38)20-39-17-22-10-4-1-5-11-22/h1-15,21,25-27,29,38H,16-20H2,(H2,33,35,36)/t25-,26+,27+,29+/m1/s1